- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.12.25 | BioNexus Gene Lab: Aktionäre billigen Vorstand, Eigenkapital-Plan und Wirtschaftsprüfer | 2 | Investing.com Deutsch | ||
| 23.12.25 | BioNexus Gene Lab Corp - 8-K, Current Report | - | SEC Filings | ||
| 03.12.25 | BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics | 1 | Investing.com | ||
| 03.12.25 | BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard | 3 | GlobeNewswire (USA) | ||
| BIONEXUS GENE LAB Aktie jetzt für 0€ handeln | |||||
| 02.12.25 | BioNexus-Aktie gibt nach Sicherung einer 500-Millionen-Dollar-Finanzierung nach | 6 | Investing.com Deutsch | ||
| 02.12.25 | BioNexus Gene Lab sichert sich Eigenkapital-Kaufvereinbarung über 500 Mio. USD | 1 | Investing.com Deutsch | ||
| 02.12.25 | BioNexus-Aktie steigt nach Sicherung einer Eigenkapitalfazilität über 500 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 02.12.25 | BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization | 113 | GlobeNewswire (Europe) | SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BGLC" or the "Company"), an emerging provider of precision oncology diagnostics with expanding operations across Southeast... ► Artikel lesen | |
| 02.12.25 | BioNexus Gene Lab Corp - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.11.25 | BioNexus-Aktie schießt nach strategischen Vereinbarungen für MRD-Tests in die Höhe | 3 | Investing.com Deutsch | ||
| 12.11.25 | BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform | 2 | Investing.com | ||
| 12.11.25 | BioNexus Gene Lab Corp - 8-K, Current Report | - | SEC Filings | ||
| 10.11.25 | BioNexus Gene Lab files $100M shelf registration and establishes $20M at-the-market program | 1 | Seeking Alpha | ||
| 10.11.25 | BioNexus Gene Lab files $100 million shelf registration, launches ATM program | 1 | Investing.com | ||
| 23.10.25 | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 20.10.25 | BioNexus Gene Lab Corp.: BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc. | 381 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, "BGLC", or the "Company"), today announced that it has entered into a non-binding Strategic Partnership... ► Artikel lesen | |
| 18.08.25 | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 30.07.25 | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 30.07.25 | BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance-Touted as a new "DeepSeek Moment" in Precision Oncology | 13 | GlobeNewswire (USA) |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DRAEGERWERK | 70,10 | 0,00 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| EKSO BIONICS | 8,540 | 0,00 % | H.C. Wainwright stuft Ekso Bionics nach Fusionsankündigung auf "Neutral" herab | ||
| INTELLIGENT BIO SOLUTIONS | 11,000 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 45,350 | +1,00 % | SIEMENS HEALTHINEERS AG im strukturellen Gleichgewicht | ||
| ALIGNMENT HEALTHCARE | 21,020 | 0,00 % | Piper Sandler raises Alignment Healthcare stock price target to $30 on strong sales | ||
| FRESENIUS MEDICAL CARE | 39,980 | -1,28 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,260 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 33,130 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | +3,22 % | CARL ZEISS MEDITEC AG zündet - TecDAX-Gewinner mit Sogwirkung! | ||
| BETA BIONICS | 29,570 | +1,09 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROGYNY | 26,645 | +3,52 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| CERIBELL | 20,810 | 0,00 % | Protara, CeriBell rise on FDA breakthrough designations | ||
| AVEANNA HEALTHCARE | 8,220 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| PACS GROUP | 39,720 | +0,51 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ADAPTHEALTH | 9,780 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber |
Das Unternehmen BIONEXUS GENE LAB CORP kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 4,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIONEXUS GENE LAB CORP finden Sie auf Wallstreet Online.